PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

First-in-human implants for Amber Therapeutics’ bioelectrical therapy

Amber-UI presents a significant opportunity to treat urge and mixed urinary incontinence. Amber Therapeutics – an Oxford University spin-off developing next-gener...
Continue Reading →
News

Memo Therapeutics reveals positive AntiBKV data

Therapy involves renal transplant patients requiring treatment of BK polyomavirus infection. Memo Therapeutics – a company that focuses on antibody discovery – ha...
Continue Reading →
News

First patients enrolled for Priothera’s mocravimod trial

Treatment is a maintenance therapy for certain patients with acute myeloid leukaemia Priothera – a company focused on the development of a sphingosine 1 phosphate...
Continue Reading →
News

OxSonics trial produces positive SonoTran data

During the research, SonoTran is being evaluated in patients with metastatic colorectal cancer. OxSonics Therapeutics – a company focused on cancer treatment thro...
Continue Reading →
News

NICE recommends Takeda’s Ninlaro triplet regimen

Therapy involves patients living with relapsed or refractory multiple myeloma. Takeda has announced that the National Institute for Health and Care Excellence (NI...
Continue Reading →
News

NeoPhore gains additional financing for discovery pipeline

The new funding package will be used to progress NeoPhore’s expanding pipeline of therapies. NeoPhore – a small molecule neoantigen immuno-oncology company – has ...
Continue Reading →
News

Stada and Xbrane receive approval for Ximluci

Biosimilar gains MHRA marketing authorisation for use throughout Britain. Stada and Xbrane have announced that the UK’s Medicines and Healthcare products Regulato...
Continue Reading →
News

Medicines Discovery Catapult and SMi gain cancer biomarker funding

Industry-first cancer screening technology boosted by biomedical grant funding. SMi and the Medicines Discovery Catapult (MDC) have secured a biomedical catalyst ...
Continue Reading →
News

Celadon receives good manufacturing practice approval

MHRA approval relates to the company’s midlands-based drug development facilities. Celadon – a company focused on the development of cannabis-based medicines – ha...
Continue Reading →
News

AbbVie and Eli Lilly snub drug pricing agreement

Major industry names depart leaving UK pricing deal in serious jeopardy. Global pharma giants, AbbVie and Eli Lilly and Company (Lilly), have shocked the UK Gover...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026